Actionable news
0
All posts from Actionable news
Actionable news in MYL: Mylan Inc.,

Mylan Advances Access in the Fight Against HIV with the Launch of Three Generic Antiretroviral Medicines in Canada

HERTFORDSHIRE, England and PITTSBURGH and TORONTO, Aug. 10, 2017 /PRNewswire/ -- Mylan Pharmaceuticals ULC, a subsidiary of Mylan N.V. (NASDAQ, TASE: MYL), a leading global pharmaceutical company, today announced the launch in Canada of three generic products indicated in the treatment of HIV for certain patients. One of the products is Mylan-Emtricitabine/Tenofovir Disoproxil Fumarate 200 mg/300 mg, a generic alternative to Truvada®.

Mylan received final approval from Health Canada for this product and for Mylan-Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate 600 mg, 200 mg, and 300 mg, a generic alternative to Atripla®; and Mylan-Tenofovir Disoproxil 300 mg, a generic alternative to Viread®.

Mylan's Chief Commercial Officer Tony Mauro said, "Mylan has a strong and sustained commitment to expanding access to treatment for HIV/AIDS and other diseases around the world, and today marks another milestone in those efforts. More than 40%...


More